Can weight-loss drug Ozempic help reduce alcohol consumption?
A new study published in the JAMA Psychiatry gives the strongest evidence that semaglutide — the active ingredient in Ozempic and the weight-loss drug Wegovy — could genuinely help individuals struggling with alcohol addiction drink less and crave alcohol less frequently. The study is the first-ever controlled trial examining the drug’s impact on alcohol consumption
The research published in JAMA Psychiatry provides the strongest evidence yet that semaglutide—the active ingredient in Ozempic and the weight-loss drug Wegovy—could genuinely help individuals struggling with alcohol addiction drink less and crave alcohol less frequently. Reuters
Discover more from Now World View
Subscribe to get the latest posts sent to your email.